These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33041859)

  • 1. Increased Transglutaminase 2 Expression and Activity in Rodent Models of Obesity/Metabolic Syndrome and Aging.
    Penumatsa KC; Falcão-Pires I; Leite S; Leite-Moreira A; Bhedi CD; Nasirova S; Ma J; Sutliff RL; Fanburg BL
    Front Physiol; 2020; 11():560019. PubMed ID: 33041859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tissue transglutaminase in age-associated ventricular stiffness.
    Oh YJ; Pau VC; Steppan J; Sikka G; Bead VR; Nyhan D; Levine BD; Berkowitz DE; Santhanam L
    Amino Acids; 2017 Mar; 49(3):695-704. PubMed ID: 27438265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension.
    Penumatsa KC; Toksoz D; Warburton RR; Kharnaf M; Preston IR; Kapur NK; Khosla C; Hill NS; Fanburg BL
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L752-L762. PubMed ID: 28775095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise, vascular stiffness, and tissue transglutaminase.
    Steppan J; Sikka G; Jandu S; Barodka V; Halushka MK; Flavahan NA; Belkin AM; Nyhan D; Butlin M; Avolio A; Berkowitz DE; Santhanam L
    J Am Heart Assoc; 2014 Apr; 3(2):e000599. PubMed ID: 24721796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing tissue transglutaminase mediated vascular smooth muscle cell aging using a novel transamidation-deficient Tgm2-C277S mouse model.
    Wang H; Chen J; Jandu S; Melucci S; Savage W; Nandakumar K; Kang SK; Barreto-Ortiz S; Poe A; Rastogi S; Bauer M; Steppan J; Santhanam L
    Cell Death Discov; 2021 Jul; 7(1):197. PubMed ID: 34326316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse.
    Reed AL; Tanaka A; Sorescu D; Liu H; Jeong EM; Sturdy M; Walp ER; Dudley SC; Sutliff RL
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H824-31. PubMed ID: 21724869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments.
    Al-U'datt DGF; Tranchant CC; Al-Dwairi A; Alqudah M; Al-Shboul O; Hiram R; Allen BG; Jaradat S; Alqbelat J; Abu-Zaiton AS
    Biochem Pharmacol; 2022 Jul; 201():115104. PubMed ID: 35617996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline chronic kidney disease is associated with upregulation of transglutaminase 2: a collagen cross-linking enzyme.
    Sánchez-Lara AC; Elliott J; Syme HM; Brown CA; Haylor JL
    Vet Pathol; 2015 May; 52(3):513-23. PubMed ID: 25047228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of transglutaminase 2 (TG2) ameliorates ventricular fibrosis in isoproterenol-induced heart failure in rats.
    Al-U'datt DGF; Tranchant CC; Alu'datt M; Abusara S; Al-Dwairi A; AlQudah M; Al-Shboul O; Hiram R; Altuntas Y; Jaradat S; Alzoubi KH
    Life Sci; 2023 May; 321():121564. PubMed ID: 36931499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung-specific interleukin 6 mediated transglutaminase 2 activation and cardiopulmonary fibrogenesis.
    Penumatsa KC; Sharma Y; Warburton RR; Singhal A; Toksoz D; Bhedi CD; Qi G; Preston IR; Anderlind C; Hill NS; Fanburg BL
    Front Immunol; 2024; 15():1371706. PubMed ID: 38650935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystamine reduces vascular stiffness in Western diet-fed female mice.
    Ramirez-Perez FI; Cabral-Amador FJ; Whaley-Connell AT; Aroor AR; Morales-Quinones M; Woodford ML; Ghiarone T; Ferreira-Santos L; Jurrissen TJ; Manrique-Acevedo CM; Jia G; DeMarco VG; Padilla J; Martinez-Lemus LA; Lastra G
    Am J Physiol Heart Circ Physiol; 2022 Feb; 322(2):H167-H180. PubMed ID: 34890280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
    Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
    J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice.
    Jung SM; Jandu S; Steppan J; Belkin A; An SS; Pak A; Choi EY; Nyhan D; Butlin M; Viegas K; Avolio A; Berkowitz DE; Santhanam L
    Am J Physiol Heart Circ Physiol; 2013 Sep; 305(6):H803-10. PubMed ID: 23873798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue Transglutaminase Modulates Vascular Stiffness and Function Through Crosslinking-Dependent and Crosslinking-Independent Functions.
    Steppan J; Bergman Y; Viegas K; Armstrong D; Tan S; Wang H; Melucci S; Hori D; Park SY; Barreto SF; Isak A; Jandu S; Flavahan N; Butlin M; An SS; Avolio A; Berkowitz DE; Halushka MK; Santhanam L
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model.
    van der Wildt B; Wilhelmus MMM; Beaino W; Kooijman EJM; Schuit RC; Bol JGJM; Breve JJP; Pasternack R; Lammertsma AA; Windhorst AD; Drukarch B
    EJNMMI Res; 2018 May; 8(1):39. PubMed ID: 29802556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling.
    Bhedi CD; Nasirova S; Toksoz D; Warburton RR; Morine KJ; Kapur NK; Galper JB; Preston IR; Hill NS; Fanburg BL; Penumatsa KC
    FASEB J; 2020 Jan; 34(1):930-944. PubMed ID: 31914588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase 2 Inhibitor LDN 27219 Age-Dependently Lowers Blood Pressure and Improves Endothelium-Dependent Vasodilation in Resistance Arteries.
    Pinilla E; Comerma-Steffensen S; Prat-Duran J; Rivera L; Matchkov VV; Buus NH; Simonsen U
    Hypertension; 2021 Jan; 77(1):216-227. PubMed ID: 33249864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase 2 cross-linking activity is linked to invadopodia formation and cartilage breakdown in arthritis.
    Lauzier A; Charbonneau M; Paquette M; Harper K; Dubois CM
    Arthritis Res Ther; 2012 Jul; 14(4):R159. PubMed ID: 22762273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geranylgeranylacetone reduces cardiomyocyte stiffness and attenuates diastolic dysfunction in a rat model of cardiometabolic syndrome.
    Waddingham MT; Sequeira V; Kuster DWD; Dal Canto E; Handoko ML; de Man FS; da Silva Gonçalves Bós D; Ottenheijm CA; Shen S; van der Pijl RJ; van der Velden J; Paulus WJ; Eringa EC
    Physiol Rep; 2023 Nov; 11(22):e15788. PubMed ID: 37985159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase 2 as a novel activator of LRP6/β-catenin signaling.
    Deasey S; Nurminsky D; Shanmugasundaram S; Lima F; Nurminskaya M
    Cell Signal; 2013 Dec; 25(12):2646-51. PubMed ID: 23993960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.